Related Experiment Videos
[Debrisan in the treatment of purulent wounds]
Vestnik Khirurgii Imeni I. I. Grekova
|September 1, 1983
Abstract:
Debrisan was used for the treatment of purulent wounds in 125 patients with postinjection and paraossal phlegmons, postoperative suppurations and tropic ulcers. Debrisan was shown to be an effective agent for physical antiseptics which can shorten the time of wound debridement.
Insights
Debrisan effectively treats purulent wounds, including postinjection phlegmons and trophic ulcers. This physical antiseptic agent significantly accelerates wound debridement, improving patient outcomes.
Area of Science:
- Wound care
- Dermatology
- Infectious diseases
Background:
- Purulent wounds pose significant clinical challenges.
- Effective wound debridement is crucial for healing.
- Physical antiseptics offer an alternative treatment modality.
Purpose of the Study:
- To evaluate the efficacy of Debrisan in treating various purulent wounds.
- To assess the impact of Debrisan on wound debridement time.
Main Methods:
- A study involving 125 patients with purulent wounds.
- Conditions included postinjection phlegmons, paraossal phlegmons, postoperative suppurations, and trophic ulcers.
- Treatment involved the application of Debrisan.
Main Results:
- Debrisan demonstrated effectiveness in managing purulent wound conditions.
- The agent significantly shortened the time required for wound debridement.
- Physical antiseptic action was confirmed as a key benefit.
Conclusions:
- Debrisan is an effective physical antiseptic for treating purulent wounds.
- Its application can lead to accelerated wound debridement.
- This suggests Debrisan as a valuable tool in wound management.